CO6612239A2 - Derivados de ácido carboxílico que comprenden un anillo de oxazolopiridina 2,5-sustituido - Google Patents
Derivados de ácido carboxílico que comprenden un anillo de oxazolopiridina 2,5-sustituidoInfo
- Publication number
- CO6612239A2 CO6612239A2 CO12125684A CO12125684A CO6612239A2 CO 6612239 A2 CO6612239 A2 CO 6612239A2 CO 12125684 A CO12125684 A CO 12125684A CO 12125684 A CO12125684 A CO 12125684A CO 6612239 A2 CO6612239 A2 CO 6612239A2
- Authority
- CO
- Colombia
- Prior art keywords
- substituted
- carboxylic acid
- acid derivatives
- oxazolopyridine ring
- oxazolopyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a compuestos de oxazolopirimidina de la fórmula I,en la que A, R, R, Ry X se definen como se ha indicado en las reivindicaciones. Los compuestos de la fórmula I son adecuados, p. ej., para la curación de heridas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10305042 | 2010-01-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6612239A2 true CO6612239A2 (es) | 2013-02-01 |
Family
ID=41800578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO12125684A CO6612239A2 (es) | 2010-01-14 | 2012-07-26 | Derivados de ácido carboxílico que comprenden un anillo de oxazolopiridina 2,5-sustituido |
Country Status (31)
Country | Link |
---|---|
US (1) | US8846692B2 (es) |
EP (1) | EP2523962B1 (es) |
JP (1) | JP5841067B2 (es) |
KR (1) | KR101759128B1 (es) |
CN (1) | CN102791717B (es) |
AR (1) | AR079997A1 (es) |
AU (1) | AU2011206615B2 (es) |
BR (1) | BR112012017437B1 (es) |
CA (1) | CA2784560C (es) |
CL (1) | CL2012001972A1 (es) |
CO (1) | CO6612239A2 (es) |
CY (1) | CY1115055T1 (es) |
DK (1) | DK2523962T3 (es) |
ES (1) | ES2441954T3 (es) |
HK (1) | HK1178885A1 (es) |
HR (1) | HRP20140179T1 (es) |
IL (1) | IL220720A (es) |
MA (1) | MA33917B1 (es) |
MX (1) | MX2012007834A (es) |
MY (1) | MY156550A (es) |
NZ (1) | NZ601113A (es) |
PL (1) | PL2523962T3 (es) |
PT (1) | PT2523962E (es) |
RS (1) | RS53254B (es) |
RU (1) | RU2564018C2 (es) |
SG (1) | SG182484A1 (es) |
SI (1) | SI2523962T1 (es) |
TW (1) | TWI510242B (es) |
UY (1) | UY33179A (es) |
WO (1) | WO2011086079A1 (es) |
ZA (1) | ZA201204174B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR079980A1 (es) | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de oxazolopirimidina sustituida en 2,5,7 |
UY33177A (es) | 2010-01-13 | 2011-08-31 | Sanofi Aventis | Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido |
SG182474A1 (en) * | 2010-01-14 | 2012-08-30 | Sanofi Sa | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
EP2523963B1 (de) | 2010-01-14 | 2014-08-27 | Sanofi | 2,5-substituierte oxazolopyrimidinderivate als edg-1 agonisten |
US9321787B2 (en) * | 2011-07-07 | 2016-04-26 | Sanofi | Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring |
EP2862574A1 (en) * | 2013-10-15 | 2015-04-22 | Sanofi | {4-[5-(3-chloro-phenoxy)-oxazolo[5,4 d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid for use in the prevention or treatment of acute kidney injury |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3679682A (en) * | 1970-04-23 | 1972-07-25 | Fmc Corp | CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES |
JPH01242587A (ja) * | 1988-03-25 | 1989-09-27 | Sankyo Co Ltd | 縮環オキサゾロチエノピリミジン誘導体 |
EP1622913A1 (en) * | 2003-04-25 | 2006-02-08 | University College Cardiff Consultants, Ltd. | Heterocyclic compounds for use in the treatment of viral infections |
WO2004096757A1 (en) * | 2003-04-30 | 2004-11-11 | Novartis Ag | Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
CL2004001120A1 (es) * | 2003-05-19 | 2005-04-15 | Irm Llc | Compuestos derivados de amina sustituidas con heterociclos, inmunosupresores; composicion farmaceutica; y uso para tratar enfermedades mediadas por interacciones de linfocito, tales como enfermedades autoinmunes, inflamatorias, infecciosas, cancer. |
SI1638551T1 (sl) * | 2003-05-19 | 2012-04-30 | Irm Llc | Imunosupresivne spojine in sestavki |
CA2619101A1 (en) * | 2005-08-23 | 2007-03-01 | Irm Llc | Immunosuppressant compounds and compositions |
AU2007227278B2 (en) * | 2007-03-21 | 2014-09-11 | Epix Pharmaceuticals, Inc. | SIP receptor modulating compounds and use thereof |
TW201000099A (en) * | 2008-06-20 | 2010-01-01 | Amgen Inc | S1P1 receptor agonists and use thereof |
CA2730843A1 (en) * | 2008-07-15 | 2010-01-21 | Sanofi-Aventis | Oxazolopyrimidines as edg-1 receptor agonists |
AR079980A1 (es) * | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de oxazolopirimidina sustituida en 2,5,7 |
UY33177A (es) * | 2010-01-13 | 2011-08-31 | Sanofi Aventis | Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido |
UY33178A (es) * | 2010-01-13 | 2011-08-31 | Sanofi Aventis | Derivados de ácido carboxílico heteroxíclicos que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido |
EP2523963B1 (de) * | 2010-01-14 | 2014-08-27 | Sanofi | 2,5-substituierte oxazolopyrimidinderivate als edg-1 agonisten |
SG182474A1 (en) * | 2010-01-14 | 2012-08-30 | Sanofi Sa | Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring |
-
2011
- 2011-01-12 RS RS20140062A patent/RS53254B/en unknown
- 2011-01-12 CN CN201180013877.9A patent/CN102791717B/zh active Active
- 2011-01-12 AU AU2011206615A patent/AU2011206615B2/en active Active
- 2011-01-12 UY UY0001033179A patent/UY33179A/es not_active Application Discontinuation
- 2011-01-12 MY MYPI2012002588A patent/MY156550A/en unknown
- 2011-01-12 DK DK11700404.4T patent/DK2523962T3/en active
- 2011-01-12 PT PT117004044T patent/PT2523962E/pt unknown
- 2011-01-12 RU RU2012134630/04A patent/RU2564018C2/ru active
- 2011-01-12 WO PCT/EP2011/050301 patent/WO2011086079A1/de active Application Filing
- 2011-01-12 SG SG2012051405A patent/SG182484A1/en unknown
- 2011-01-12 JP JP2012548410A patent/JP5841067B2/ja active Active
- 2011-01-12 KR KR1020127021242A patent/KR101759128B1/ko active IP Right Grant
- 2011-01-12 SI SI201130094T patent/SI2523962T1/sl unknown
- 2011-01-12 NZ NZ601113A patent/NZ601113A/xx unknown
- 2011-01-12 US US13/521,831 patent/US8846692B2/en active Active
- 2011-01-12 AR ARP110100092A patent/AR079997A1/es active IP Right Grant
- 2011-01-12 TW TW100101053A patent/TWI510242B/zh active
- 2011-01-12 MX MX2012007834A patent/MX2012007834A/es active IP Right Grant
- 2011-01-12 MA MA35055A patent/MA33917B1/fr unknown
- 2011-01-12 ES ES11700404.4T patent/ES2441954T3/es active Active
- 2011-01-12 CA CA2784560A patent/CA2784560C/en active Active
- 2011-01-12 PL PL11700404T patent/PL2523962T3/pl unknown
- 2011-01-12 EP EP11700404.4A patent/EP2523962B1/de active Active
- 2011-01-12 BR BR112012017437-1A patent/BR112012017437B1/pt active IP Right Grant
-
2012
- 2012-06-07 ZA ZA2012/04174A patent/ZA201204174B/en unknown
- 2012-07-02 IL IL220720A patent/IL220720A/en active IP Right Grant
- 2012-07-13 CL CL2012001972A patent/CL2012001972A1/es unknown
- 2012-07-26 CO CO12125684A patent/CO6612239A2/es unknown
-
2013
- 2013-05-10 HK HK13105591.7A patent/HK1178885A1/xx unknown
-
2014
- 2014-01-30 CY CY20141100079T patent/CY1115055T1/el unknown
- 2014-02-26 HR HRP20140179AT patent/HRP20140179T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121776T1 (el) | C17-αλκανοδιυλιο και παραγωγα αλκενοδιυλιου του ολεανολικου οξεος και μεθοδοι χρησης αυτων | |
CY1121744T1 (el) | Παραγωγα c4-μονομεθυλο-τριτερπενοειδους και μεθοδοι χρησης αυτων | |
UY33227A (es) | Compuestos de pirrolopirimidina como inhibidores de la cdk4/6 | |
UY33176A (es) | Derivados de oxazolopirimidina sustituida en 2, 5, 7. | |
ECSP11011244A (es) | Nuevos herbicidas. | |
CR20120410A (es) | Pirrolidina-2-carboxamidas sustituidas | |
CO6541606A2 (es) | Espiroindolinona- pirrolidinas | |
BR112012033350A2 (pt) | "composição e métodos para modular a via de sinalização de wnt" | |
CO6491116A2 (es) | Derivados de 5-fluoropirimidinona | |
UY32863A (es) | COMPUESTOS DE HEXAHIDROOXAZINOPTERINA PARA USO COMO INHIBIDORES DE mTOR | |
UY34318A (es) | ?derivados de isotiazolina útiles como compuestos insecticidas? | |
CR20140468A (es) | Inhibidores de diacilglicerol aciltransferasa 2 | |
CO6612239A2 (es) | Derivados de ácido carboxílico que comprenden un anillo de oxazolopiridina 2,5-sustituido | |
ECSP11011218A (es) | Herbicidas derivados de ciclopentanodiona. | |
UY34251A (es) | derivados de isoxazolina como compuestos insecticidas. | |
ECSP11011245A (es) | Novedosos herbicidas | |
CO6852083A2 (es) | Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas | |
MA33948B1 (fr) | Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques. | |
ECSP11011485A (es) | Espiro-epóxidos como productos intermedios. | |
UY33177A (es) | Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido | |
CR20150397A (es) | Composiciones herbicidas | |
UY33180A (es) | Derivados de ácido carboxílico heterocíclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida. | |
UY33864A (es) | Novedoso Derivado Cristalino de Oxazina | |
ECSP13012914A (es) | Síntesis de derivados de 2-carboxamida-cicloamino-urea | |
UY33178A (es) | Derivados de ácido carboxílico heteroxíclicos que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido |